Skip to main content
INVA logo

Innoviva, Inc.

INVANASDAQHealthcareBiotechnology

$20.66Today:- (-)1Y +15.33%

As of Oct 23, 2026 close

Market cap
$1.52B
P/E (TTM)
4.25
Forward P/E
2.42
Dividend yield
-
52-week range
$17.13$25.15
Volume (live)
-
Avg. volume (3M)
895.89K

Innoviva (INVA) Financial Ratios

For fiscal 2025 (fiscal year ended Dec 31, 2025), Innoviva had a P/E ratio of 5.51 (down from 46.43), return on equity of 29.1% (up from 3.4%), debt-to-equity of 0.28 (down from 0.75) and a current ratio of 14.64 (up from 2.35). A current ratio of 14.64 means current assets exceed current liabilities.

Innoviva Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio5.5146.435.724.324.515.60
Forward P/E9.6710.9119.569.7410.076.73
P/S Ratio3.633.033.312.793.063.73
P/B Ratio1.271.571.521.632.282.07
Price/Tangible Book1.542.342.413.232.892.33
Price/FCF7.635.767.314.583.294.01
Price/OCF7.595.767.294.583.294.01
PEG Ratio0.280.320.320.320.32-
Enterprise Value Ratios
EV/Revenue3.123.764.403.523.943.59
EV/EBITDA6.596.528.395.244.123.75
EV/EBIT7.627.469.695.384.123.75
EV/FCF6.567.159.725.794.253.87
Profitability & Returns
Return on Equity (ROE)29.10%3.43%28.97%40.35%65.06%61.86%
Return on Assets (ROA)7.18%8.88%7.12%12.57%24.35%23.40%
Return on Invested Capital (ROIC)16.11%12.56%13.82%20.71%42.39%48.01%
Return on Capital Employed (ROCE)10.60%17.00%11.70%19.80%40.70%32.50%
Leverage & Solvency Ratios
Debt/Equity0.280.750.771.090.750.63
Debt/EBITDA1.692.503.142.741.051.19
Debt/FCF1.692.763.693.051.081.23
Liquidity Ratios
Current Ratio14.642.359.033.2954.0255.98
Quick Ratio13.282.117.282.6353.7755.72
Efficiency Ratios
Asset Turnover0.280.280.250.310.410.39
Inventory Turnover2.830.960.97---
Yield & Distribution Ratios
Earnings Yield18.14%2.15%17.48%23.14%22.18%17.86%
FCF Yield13.10%17.35%13.68%21.81%30.35%24.92%
Buyback Yield-14.25%14.61%8.79%-0.99%16.95%-0.13%
Total Return-14.25%14.61%8.79%-0.99%16.95%-0.13%

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Innoviva Financial Ratios

What is Innoviva's P/E ratio?

Innoviva's P/E ratio was 5.51 for fiscal 2025 (period ended Dec 31, 2025). It was 46.43 a year earlier.

What is Innoviva's return on equity?

Innoviva's return on equity (ROE) was 29.1% for fiscal 2025 (period ended Dec 31, 2025). It was 3.4% a year earlier.

What is Innoviva's debt-to-equity ratio?

Innoviva's debt-to-equity ratio was 0.28 for fiscal 2025 (period ended Dec 31, 2025). It was 0.75 a year earlier.

What is return on equity (ROE)?

Return on equity is net income divided by shareholders' equity. It measures how much profit a company generates from the capital its shareholders have invested. Full definition